Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03942419
Recruitment Status : Recruiting
First Posted : May 8, 2019
Last Update Posted : August 30, 2019
Sponsor:
Information provided by (Responsible Party):
Eyenovia Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2023
Estimated Study Completion Date : May 2024